These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2660675)

  • 1. In vivo biologic activities of recombinant human granulocyte-macrophage colony-stimulating factor.
    Vadhan-Raj S; Hittelman WN; Broxmeyer HE; Keating M; Urdal D; Gutterman JU
    Ann N Y Acad Sci; 1989; 554():231-40. PubMed ID: 2660675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of hematopoiesis in patients with bone marrow failure and in patients with malignancy by recombinant human granulocyte-macrophage colony-stimulating factor.
    Vadhan-Raj S; Buescher S; LeMaistre A; Keating M; Walters R; Ventura C; Hittelman W; Broxmeyer HE; Gutterman JU
    Blood; 1988 Jul; 72(1):134-41. PubMed ID: 3291976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of myelopoiesis in patients with aplastic anemia by recombinant human granulocyte-macrophage colony-stimulating factor.
    Vadhan-Raj S; Buescher S; Broxmeyer HE; LeMaistre A; Lepe-Zuniga JL; Ventura G; Jeha S; Horwitz LJ; Trujillo JM; Gillis S
    N Engl J Med; 1988 Dec; 319(25):1628-34. PubMed ID: 3059191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematopoietic responses in patients with advanced malignancy treated with recombinant human granulocyte-macrophage colony-stimulating factor.
    Herrmann F; Schulz G; Lindemann A; Meyenburg W; Oster W; Krumwieh D; Mertelsmann R
    J Clin Oncol; 1989 Feb; 7(2):159-67. PubMed ID: 2644395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of myelopoiesis in a patient with congenital neutropenia: biology and nature of response to recombinant human granulocyte-macrophage colony-stimulating factor.
    Vadhan-Raj S; Jeha SS; Buescher S; LeMaistre A; Yee G; Lu L; Lloreta J; Hoots WK; Hittelman WN; Gutterman JU
    Blood; 1990 Feb; 75(4):858-64. PubMed ID: 2405922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation.
    Brandt SJ; Peters WP; Atwater SK; Kurtzberg J; Borowitz MJ; Jones RB; Shpall EJ; Bast RC; Gilbert CJ; Oette DH
    N Engl J Med; 1988 Apr; 318(14):869-76. PubMed ID: 3281007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of human hematopoietic progenitor cell proliferation and differentiation by recombinant human interleukin 3. Comparison and interactions with recombinant human granulocyte-macrophage and granulocyte colony-stimulating factors.
    Ottmann OG; Abboud M; Welte K; Souza LM; Pelus LM
    Exp Hematol; 1989 Feb; 17(2):191-7. PubMed ID: 2463933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematologic effects of recombinant murine granulocyte-macrophage colony-stimulating factor on the peripheral blood and bone marrow.
    Ulich TR; del Castillo J; McNiece I; Watson L; Yin SM; Andresen J
    Am J Pathol; 1990 Aug; 137(2):369-76. PubMed ID: 1696784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I study of intravenously administered bacterially synthesized granulocyte-macrophage colony-stimulating factor and comparison with subcutaneous administration.
    Lieschke GJ; Maher D; O'Connor M; Green M; Sheridan W; Rallings M; Bonnem E; Burgess AW; McGrath K; Fox RM
    Cancer Res; 1990 Feb; 50(3):606-14. PubMed ID: 2404573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant GM-CSF in patients with poor graft function after bone marrow transplantation.
    Klingemann HG; Eaves AC; Barnett MJ; Reece DE; Shepherd JD; Belch AR; Brandwein JM; Langleben A; Koch PA; Phillips GL
    Clin Invest Med; 1990 Apr; 13(2):77-81. PubMed ID: 2191816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of bacterially synthesized recombinant human granulocyte-macrophage colony-stimulating factor in patients with advanced malignancy.
    Lieschke GJ; Maher D; Cebon J; O'Connor M; Green M; Sheridan W; Boyd A; Rallings M; Bonnem E; Metcalf D
    Ann Intern Med; 1989 Mar; 110(5):357-64. PubMed ID: 2644886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I study of recombinant human granulocyte-macrophage colony-stimulating factor in patients with bone marrow failure and malignancy.
    Vadhan-Raj S; Kellagher MJ; Keating M; Walters R; Gutterman JU
    Behring Inst Mitt; 1988 Aug; (83):119-24. PubMed ID: 2467646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological effects of recombinant human GM-CSF.
    Shadduck RK; Kaplan SS; Whiteside TL; Wing EJ
    Prog Clin Biol Res; 1990; 352():365-74. PubMed ID: 2169633
    [No Abstract]   [Full Text] [Related]  

  • 14. Stimulation of nonclonal hematopoiesis and suppression of the neoplastic clone after treatment with recombinant human granulocyte-macrophage colony-stimulating factor in a patient with therapy-related myelodysplastic syndrome.
    Vadhan-Raj S; Broxmeyer HE; Spitzer G; LeMaistre A; Hultman S; Ventura G; Tigaud JD; Cork MA; Trujillo JM; Gutterman JU
    Blood; 1989 Oct; 74(5):1491-8. PubMed ID: 2676013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience with recombinant human granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor.
    Morstyn G; Lieschke GJ; Sheridan W; Layton J; Cebon J; Fox RM
    Semin Hematol; 1989 Apr; 26(2 Suppl 2):9-13. PubMed ID: 2471275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) shortens the period of neutropenia after autologous bone marrow transplantation in a primate model.
    Nienhuis AW; Donahue RE; Karlsson S; Clark SC; Agricola B; Antinoff N; Pierce JE; Turner P; Anderson WF; Nathan DG
    J Clin Invest; 1987 Aug; 80(2):573-7. PubMed ID: 3301903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human granulocyte-macrophage colony-stimulating factor in patients with advanced malignancy: a phase Ib trial.
    Steis RG; VanderMolen LA; Longo DL; Clark JW; Smith JW; Kopp WC; Ruscetti FW; Creekmore SP; Elwood LJ; Hursey J
    J Natl Cancer Inst; 1990 Apr; 82(8):697-703. PubMed ID: 2138680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yeast-expressed granulocyte-macrophage colony-stimulating factor in cancer patients: a phase ib clinical study.
    Herrmann F; Schulz G; Lindemann A; Meyenburg W; Oster W; Krumwieh D; Mertelsmann R
    Behring Inst Mitt; 1988 Aug; (83):107-18. PubMed ID: 2467645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical role of granulocyte-macrophage colony-stimulating factor.
    Mitsuyasu RT; Golde DW
    Hematol Oncol Clin North Am; 1989 Sep; 3(3):411-25. PubMed ID: 2698875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of recombinant human granulocyte colony stimulating factor and granulocyte-monocyte colony stimulating factor on in vitro hemopoiesis in the myelodysplastic syndromes.
    Nagler A; Ginzton N; Negrin R; Bang D; Donlon T; Greenberg P
    Leukemia; 1990 Mar; 4(3):193-202. PubMed ID: 1690318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.